Trial
NCT06078696
Siplizumab for Sickle Cell Disease Transplant
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Columbia University
Collaborators
ITB-Med LLC
Condition
Anemia, Sickle Cell
Intervention
Siplizumab
Why stopped
Closed by the industry collaborator
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-10